Event
Three Site’s a Charm: The Importance of Extragenital Testing for MSM
Join NCSD on Thursday, August 29 (12:00PM-1:30PM ET) for an informative webinar about the importance of extragenital screening of MSM and hear some real-world examples of how STD programs and clinics are incorporating it into their work, and the impact it has had.
Description
Data shows that men who have sex with men (MSM) are disproportionally impacted by the rises in chlamydia, gonorrhea, and syphilis infections. To combat these rises, it is key that medical providers and health departments use extragenital STD screening, or 3-site testing, to detect STDs and have people treated as soon as possible. This webinar is a product of NCSD’s MSM Advisory Committee, which makes recommendations and establishes program priorities to enhance the capacity and services of NCSD members around gay men’s sexual health.
Featured Speakers
Kacie Taylor
Western Regional Consultant, Colorado Dept. of Public Health & Environment
Ami Multani, MD
Physician & Medical Director of Infectious Disease – Fenway Health (Boston, MA)
Rachel Howard, MPH
STD Epidemiologist – Maricopa County Dept. of Public Health (Phoenix, AZ)
Daniel Daltry, MSW
Program Chief, HIV, STD, and Hepatitis Program – Vermont Dept. of Health
Objectives
This webinar aims to provide an overview of the peer-reviewed literature related to extragenital STD screening of MSM, in addition to highlight examples from the STD field. Attendees will be learn the value of:
- using comprehensive sexual histories to identify which anatomical sites need to be tested
- successfully incorporating self-collection of pharyngeal and rectal specimens for extragenital STD testing
- successfully capturing anatomical site of reported chlamydia and gonorrhea cases through surveillance
